arrow
P

Paweł Balsam

Medical University of Warsaw
H指数:26
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Artificial Intelligence in Cardiology: An Evidence Map Across Subspecialties, 2014–2026

心血管病学中的人工智能:跨亚专业领域的证据图谱,2014–2026

2026-09-230
OAAI
Usability of CHA2DS2VASC score in predicting the effectiveness and safety of pharmacological cardioversion – data from the multicenter cardioversion with intravenous ANTazoline study

CHA2DS2VASC评分在预测药物复律有效性和安全性方面的可用性——来自多中心静脉注射ANTazoline复律研究的数据

2025-10-200
OAAI
Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study

17,000例以上心房颤动患者脉冲场消融安全性的MANIFEST-17K研究

2024-07-0822
OA
AssistMED project: Transforming cardiology cohort characterisation from electronic health records through natural language processing - Algorithm design, preliminary results, and field prospects

AssistMED项目: 通过自然语言处理从电子健康记录中转换心脏病学队列特征-算法设计,初步结果和现场前景

2024-05-012
PRE
Practical use case of natural language processing for observational clinical research data retrieval from electronic health records: AssistMED project

从电子健康记录中检索观察性临床研究数据的自然语言处理的实际用例: AssistMED项目

2024-03-191
OA
Antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation and sex differences: Insights from the CANT II Study
2023-11-303
OA
Impact of AfterAMI Mobile App on Quality of Life, Depression, Stress and Anxiety in Patients with Coronary Artery Disease: Open Label, Randomized Trial

AfterAMI移动应用程序对冠心病患者生活质量,抑郁,压力和焦虑的影响: 开放标签,随机试验

2023-10-051
OAAI
Mobile application and digital system for patients after myocardial infarction: early results from a randomized trial

心肌梗死后患者的移动应用程序和数字系统: 一项随机试验的早期结果

2023-03-032
OA
Heart failure in patients with atrial fibrillation: Insights from Polish part of the EORP-AF general long-term registry

房颤患者的心力衰竭:来自EORP-AF全球长期注册研究波兰分中心的见解

2022-11-224
OA
Fifteen-Year Differences in Indications for Cardiac Resynchronization Therapy in International Guidelines-Insights from the Heart Failure Registries of the European Society of Cardiology

国际指南中心脏再同步治疗适应症的15年差异-来自欧洲心脏病学会心力衰竭注册中心的见解

2022-06-062
OAAI
Efficacy and safety of antazoline for cardioversion of atrial fibrillation: propensity score matching analysis of a multicenter registry (CANT II Study)
2022-03-1614
OA